Health

Allergan settles Alzheimer's therapy lawsuit for $750 million


The Allergan logo is seen in this photo illustration November 23, 2015. REUTERS/Thomas White/Illustration/File Photo

(Reuters) – Allergan Plc said on Monday it had settled a class action lawsuit brought by a group of direct purchasers of Alzheimer’s disease therapy Namenda, resolving the litigation that was set to face trial this month.

Under the agreement, the drugmaker’s Forest units will pay $750 million to the plaintiff, which will be recorded as a charge in its third-quarter results.

The company said the settlement makes no admission of wrongdoing on its part.

Reporting by Saumya Sibi Joseph in Bengaluru; Editing by Arun Koyyur



READ SOURCE

Leave a Reply

This website uses cookies. By continuing to use this site, you accept our use of cookies.